These data are consistent with the observed role of β-arrestin1 in impeding p62/SQSTM1 flux and impairing destruction of misfolded tau (83) and underline the potential of β-arrestin proteins as drug targets for the therapy of neurodegenerative diseases. The gene discussed is SQSTM1; the disease is neurodegenerative disease.